Reprint
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
Edited by
April 2022
208 pages
- ISBN978-3-0365-3746-7 (Hardback)
- ISBN978-3-0365-3745-0 (PDF)
This book is a reprint of the Special Issue Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
This Special Issue contributes original research and review articles on the role of new protein, molecular, and genetic markers used for the diagnosis and progression of civilization diseases, as well as biomarkers useful in the monitoring the effects of the implemented treatment.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
pharmacogenomics; NGS variants; personalized medicine; FSHR; pharmacogenomics; personalized drug therapy; hedgehog-interacting protein; impaired fasting glucose; impaired glucose tolerance; newly diagnosed diabetes; normal glucose tolerance; inflammatory bowel disease; ulcerative colitis; Crohn’s disease; extracellular matrix components; hyaluronan; inflammatory bowel diseases (IBD); Crohn’s disease (CD); ulcerative colitis (UC); sulfated glycosaminoglycans (sGAG); hyaluronan (HA); soluble part of syndecan-1 (sCD138); microRNA; cardiovascular disease; diabetes; mortality; antiplatelet therapy; platelet reactivity; Let-7e; miR-126; miR-223; miR-125a-3p; CCL11; CCL24; CCL26; CCR3; CRC; adiponectin; adipokines; rheumatology; obesity; overweight; case control study; rheumatoid arthritis; TNF-α inhibitors; bone turnover markers; PINP; PICP; NTX-I; CTX-I; RANKL/OPG; ovarian cancer; interleukin 21; interleukin 22; ulcerative colitis; lymphocytes; macrophages; dendritic cells; innate lymphoid cells; breast cancer; extracellular matrix; proteins; tumorigenesis; tumor microenvironment